Literature DB >> 17786630

Mechanisms regulating human FMO3 transcription.

David E Klick1, Ronald N Hines.   

Abstract

Flavin-containing monooxygenases (FMOs) are important oxidative drug metabolizing enzymes. FMO3 is the primary human adult liver FMO enzyme, but is developmentally regulated. FMO3 promoter characterization using in vitro DNA binding assays with HepG2 cell and fetal and adult liver nuclear protein, as well as FMO3/reporter construct transient expression in HepG2 cells, provided evidence for specific mechanisms contributing to both developmental and constitutive adult regulation. NFY, USF1, an unidentified GC box binding protein, and YY1 appear to play major roles regulating constitutive FMO3 transcription, while Pbx(2) as a heterodimer with an unidentified Hox isoform also may contribute to FMO3 developmental expression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17786630     DOI: 10.1080/03602530701498612

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


  11 in total

1.  Flavin-containing monooxygenase-3: induction by 3-methylcholanthrene and complex regulation by xenobiotic chemicals in hepatoma cells and mouse liver.

Authors:  Trine Celius; Andrea Pansoy; Jason Matthews; Allan B Okey; Marilyn C Henderson; Sharon K Krueger; David E Williams
Journal:  Toxicol Appl Pharmacol       Date:  2010-06-04       Impact factor: 4.219

Review 2.  Gene expression profiling as an initial approach for mechanistic studies of toxicity and tumorigenicity of herbal plants and herbal dietary supplements.

Authors:  Lei Guo; Nan Mei; Qingsu Xia; Tao Chen; Po-Chuen Chan; Peter P Fu
Journal:  J Environ Sci Health C Environ Carcinog Ecotoxicol Rev       Date:  2010-01       Impact factor: 3.781

3.  Ginkgo biloba extract induces gene expression changes in xenobiotics metabolism and the Myc-centered network.

Authors:  Lei Guo; Nan Mei; Wayne Liao; Po-Chuen Chan; Peter P Fu
Journal:  OMICS       Date:  2010-02

4.  Trimethylaminuria: causes and diagnosis of a socially distressing condition.

Authors:  Richard J Mackay; Christopher J McEntyre; Caroline Henderson; Michael Lever; Peter M George
Journal:  Clin Biochem Rev       Date:  2011-02

5.  Inter-individual variation in flavin-containing monooxygenase 3 in livers from Japanese: correlation with hepatic transcription factors.

Authors:  Satomi Nagashima; Makiko Shimizu; Hiroshi Yano; Norie Murayama; Toshio Kumai; Shinichi Kobayashi; F Peter Guengerich; Hiroshi Yamazaki
Journal:  Drug Metab Pharmacokinet       Date:  2009       Impact factor: 3.614

6.  Hepatic flavin-containing monooxygenase gene regulation in different mouse inflammation models.

Authors:  Jun Zhang; Madhusudana R Chaluvadi; Rob Reddy; Meike S Motika; Terrilyn A Richardson; John R Cashman; Edward T Morgan
Journal:  Drug Metab Dispos       Date:  2008-12-16       Impact factor: 3.922

7.  Osmotic regulation of a novel flavin-containing monooxygenase in primary cultured cells from rainbow trout (Oncorhynchus mykiss).

Authors:  Gabriela Rodríguez-Fuentes; Rosaura Aparicio-Fabre; Qi Li; Daniel Schlenk
Journal:  Drug Metab Dispos       Date:  2008-03-27       Impact factor: 3.922

8.  Differential Fmo3 gene expression in various liver injury models involving hepatic oxidative stress in mice.

Authors:  Swetha Rudraiah; Jamie E Moscovitz; Ajay C Donepudi; Sarah N Campion; Angela L Slitt; Lauren M Aleksunes; José E Manautou
Journal:  Toxicology       Date:  2014-09-02       Impact factor: 4.221

9.  Genetic and Nongenetic Factors Associated with Protein Abundance of Flavin-Containing Monooxygenase 3 in Human Liver.

Authors:  Meijuan Xu; Deepak Kumar Bhatt; Catherine K Yeung; Katrina G Claw; Amarjit S Chaudhry; Andrea Gaedigk; Robin E Pearce; Ulrich Broeckel; Roger Gaedigk; Deborah A Nickerson; Erin Schuetz; Allan E Rettie; J Steven Leeder; Kenneth E Thummel; Bhagwat Prasad
Journal:  J Pharmacol Exp Ther       Date:  2017-08-17       Impact factor: 4.030

10.  Oxidative stress-responsive transcription factor NRF2 is not indispensable for the human hepatic Flavin-containing monooxygenase-3 (FMO3) gene expression in HepG2 cells.

Authors:  Swetha Rudraiah; Xinsheng Gu; Ronald N Hines; José E Manautou
Journal:  Toxicol In Vitro       Date:  2015-11-23       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.